The lack of any type of news is very troubling. I have a

New Post Public Reply Private Reply Replies (1) Message Board
Bravo16
350
The lack of any type of news is very troubling. I have a bad feeling that nothing has progressed on the China front. And that nothing can progress until they acquire money from somewhere. I believe that dont want to waste the $40m equity raise on anything Corona related too risky. I think if we are to get something out of Corona it will have to be an organic money raise from investors or govt grants.

Also from some of my conversations with Todd i was led to believe that the document we signed was only a loose memorandum of understanding. No official contract had been signed. I say this because i asked specific questions about payments(the $2m breakup fee) that Todd couldn't answer because he said that info essentially had not been flushed out yet. Consequently this means that no official contract with specific detail has been signed.

A recent article in the boston globe states that Epivax still needs 5.5 million before it can move forward to create the vaccine. This was an article from the 30th. Joe's trip was in vain and there will be NO vaccine until funds are secured. Its probably too late at this point as they are a month behind everyone else.

They made a nice effort but it was a million to one for a company with no money.

Were just spinning our wheels at this point wasting valuable time that now should be spent on more important and realistic opportunities. Times up. Cut bait and focus on core.

https://www.bostonglobe.com/2020/03/30/metro/...s-vaccine/



Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 20

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 24

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 27

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 13

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 25

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 16

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Update on Danish Aerospace Company A/S Share Transactions

Updated Category News Views 262

Recent Share Transactions at Danish Aerospace Company A/S In a significant update for investors and stakeholders, Danish Aerospace Company A/S has announced recent transactions involving their shares by individuals in managerial positions and those closely associated with them. This announcement reflects compliance with the Market Abuse Regulation (EU) no. 596/2014,...

Continue Reading
Skanska's $57M Deal to Transform Del Mar Traffic

Updated Category News Views 15

A Roadway Overhaul in Del Mar A cool $57 million. That’s the ticket Skanska bought to scoop up the El Camino Real project in Del Mar, California. Think of it as a road facelift, a necessary one—it includes bulking up the corridor to four lanes and swapping in a spanking new San Dieguito River Bridge, taking the place of an old rascal that's been around for 84 years....

Continue Reading
Understanding Home Depot's Options Trading: What’s Ahead?

Updated Category News Views 147

Home Depot's Recent Options Trading Activity Recent activities in the world of finance have caught the attention of investors and analysts alike, particularly surrounding Home Depot. Our examination of the options market has unveiled an intriguing trend with significant bearish movements. With a thorough dive into the options history of Home Depot (HD), we identified 35...

Continue Reading
Boardroom Styling Lounge Enhances Membership for Men's Grooming

Updated Category News Views 272

Boardroom Styling Lounge Introduces New Membership Plan Boardroom Styling Lounge, a prominent name in the men's grooming industry, has refreshed its membership program as part of its ongoing anniversary celebrations. This initiative reflects the company's dedication to adapting to the needs of modern men while maintaining exceptional service quality. Understanding...

Continue Reading
CNA Financial's Thriving Third Quarter Earnings Show Gains

Updated Category News Views 38

Key Financial Highlights for CNA Financial's Third Quarter CNA Financial Corporation (NYSE: CNA) has released its financial results for the third quarter of 2024, showcasing robust performance across various sectors. The net income reached a commendable $283 million, translating to $1.04 per share. This is a notable increase from the previous year's quarter, where the net...

Continue Reading